Limitations of current antimicrobial therapy in the immunosuppressed host: Looking at both sides of the coin
- 30 March 1984
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 76 (3) , 101-110
- https://doi.org/10.1016/0002-9343(84)90327-9
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Acyclovir Halts Progression of Herpes Zoster in Immunocompromised PatientsNew England Journal of Medicine, 1983
- Human Cryptosporidiosis in Immunocompetent and Immunodeficient PersonsNew England Journal of Medicine, 1983
- Oral antibiotic prophylaxis in patients with cancer: A double-blind randomized placebo-controlled trialThe Journal of Pediatrics, 1983
- Early Vidarabine Therapy to Control the Complications of Herpes Zoster in Immunosuppressed PatientsNew England Journal of Medicine, 1982
- Resistance to Antiviral Drugs of Herpes Simplex Virus Isolated from a Patient Treated with AcyclovirNew England Journal of Medicine, 1982
- An Outbreak of Community-AcquiredPneumocystis cariniiPneumoniaNew England Journal of Medicine, 1981
- Acyclovir Prophylaxis of Herpes-Simplex-Virus InfectionsNew England Journal of Medicine, 1981
- A Comparison of Trimethoprim-Sulfamethoxazole plus Nystatin with Gentamicin plus Nystatin in the Prevention of Infections in Acute LeukemiaNew England Journal of Medicine, 1981
- Impaired Antibody Response to Pneumococcal Vaccine after Treatment for Hodgkin's DiseaseNew England Journal of Medicine, 1978
- Successful Chemoprophylaxis forPneumocystis cariniiPneumonitisNew England Journal of Medicine, 1977